Current role
Ashley Hall
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ashley Hall
The proxy statement of Esperion Therapeutics, Inc. reports total compensation of $2,877,249 for Ashley Hall in fiscal 2021, including a base salary of $270,063. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Structure Therapeutics Inc. (GPCR)
Proxy statement
CurrentStart not stated–present
-
Esperion Therapeutics, Inc.
Proxy statement
Start not stated–2021-04-15
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Esperion Therapeutics, Inc.
Leadership on record at Structure Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Raymond Stevens CEO, Board Member
- Jun Yoon CFO
- Matthew Lang COO, General Counsel
- Yingli Ma CTO
- Angus Russell Board Member
- Ted Love, M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Esperion Therapeutics, Inc. | Former Chief Development Officer | $270,063 | $2,877,249 |
| 2020 | Esperion Therapeutics, Inc. | Former Chief Development Officer | $435,000 | $2,300,531 |
Recent activity
No call appearances or filed executive changes recorded yet.